Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-17-000106
Filing Date
2017-01-24
Accepted
2017-01-24 18:56:55
Documents
1
Period of Report
2017-01-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_4430.html 4  
1 PRIMARY DOCUMENT doc4_4430.xml 4 5121
  Complete submission text file 0001638599-17-000106.txt   6573
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Hoenlein Malcolm (Reporting) CIK: 0001294517 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35366 | Film No.: 17544812

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Issuer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations